432 related articles for article (PubMed ID: 30523715)
1. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
[TBL] [Abstract][Full Text] [Related]
2. Triggering receptor expressed on myeloid cells 2 (TREM2) deficiency attenuates phagocytic activities of microglia and exacerbates ischemic damage in experimental stroke.
Kawabori M; Kacimi R; Kauppinen T; Calosing C; Kim JY; Hsieh CL; Nakamura MC; Yenari MA
J Neurosci; 2015 Feb; 35(8):3384-96. PubMed ID: 25716838
[TBL] [Abstract][Full Text] [Related]
3. Brain Cleanup as a Potential Target for Poststroke Recovery: The Role of RXR (Retinoic X Receptor) in Phagocytes.
Ting SM; Zhao X; Sun G; Obertas L; Ricote M; Aronowski J
Stroke; 2020 Mar; 51(3):958-966. PubMed ID: 31914884
[TBL] [Abstract][Full Text] [Related]
4. TREM2 regulates microglial phagocytosis of synapses in innate immune tolerance.
Meng J; Han L; Xu H; Zhang L; Liu Z; Zhou Y; Zhang X; Luo H; Zhang YW
Int Immunopharmacol; 2024 Jan; 127():111445. PubMed ID: 38147777
[TBL] [Abstract][Full Text] [Related]
5. Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke.
Sieber MW; Jaenisch N; Brehm M; Guenther M; Linnartz-Gerlach B; Neumann H; Witte OW; Frahm C
PLoS One; 2013; 8(1):e52982. PubMed ID: 23301011
[TBL] [Abstract][Full Text] [Related]
6. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
[TBL] [Abstract][Full Text] [Related]
7. The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity.
Filipello F; Morini R; Corradini I; Zerbi V; Canzi A; Michalski B; Erreni M; Markicevic M; Starvaggi-Cucuzza C; Otero K; Piccio L; Cignarella F; Perrucci F; Tamborini M; Genua M; Rajendran L; Menna E; Vetrano S; Fahnestock M; Paolicelli RC; Matteoli M
Immunity; 2018 May; 48(5):979-991.e8. PubMed ID: 29752066
[TBL] [Abstract][Full Text] [Related]
8. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
[TBL] [Abstract][Full Text] [Related]
9. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.
Takahashi K; Rochford CD; Neumann H
J Exp Med; 2005 Feb; 201(4):647-57. PubMed ID: 15728241
[TBL] [Abstract][Full Text] [Related]
10. Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Interacts With Colony-Stimulating Factor 1 Receptor (CSF1R) but Is Not Necessary for CSF1/CSF1R-Mediated Microglial Survival.
Cheng B; Li X; Dai K; Duan S; Rong Z; Chen Y; Lü L; Liu Z; Huang X; Xu H; Zhang YW; Zheng H
Front Immunol; 2021; 12():633796. PubMed ID: 33841415
[TBL] [Abstract][Full Text] [Related]
11. TREM2, Microglia, and Neurodegenerative Diseases.
Yeh FL; Hansen DV; Sheng M
Trends Mol Med; 2017 Jun; 23(6):512-533. PubMed ID: 28442216
[TBL] [Abstract][Full Text] [Related]
12. TREM2-activating antibodies abrogate the negative pleiotropic effects of the Alzheimer's disease variant
Cheng Q; Danao J; Talreja S; Wen P; Yin J; Sun N; Li CM; Chui D; Tran D; Koirala S; Chen H; Foltz IN; Wang S; Sambashivan S
J Biol Chem; 2018 Aug; 293(32):12620-12633. PubMed ID: 29599291
[TBL] [Abstract][Full Text] [Related]
13. Opposing roles of the triggering receptor expressed on myeloid cells 2 and triggering receptor expressed on myeloid cells-like transcript 2 in microglia activation.
Zheng H; Liu CC; Atagi Y; Chen XF; Jia L; Yang L; He W; Zhang X; Kang SS; Rosenberry TL; Fryer JD; Zhang YW; Xu H; Bu G
Neurobiol Aging; 2016 Jun; 42():132-41. PubMed ID: 27143430
[TBL] [Abstract][Full Text] [Related]
14. A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia.
Hsieh CL; Koike M; Spusta SC; Niemi EC; Yenari M; Nakamura MC; Seaman WE
J Neurochem; 2009 May; 109(4):1144-56. PubMed ID: 19302484
[TBL] [Abstract][Full Text] [Related]
15. TREM2 sustains microglial expansion during aging and response to demyelination.
Poliani PL; Wang Y; Fontana E; Robinette ML; Yamanishi Y; Gilfillan S; Colonna M
J Clin Invest; 2015 May; 125(5):2161-70. PubMed ID: 25893602
[TBL] [Abstract][Full Text] [Related]
16. Genetic models of cleavage-reduced and soluble TREM2 reveal distinct effects on myelination and microglia function in the cuprizone model.
Beckmann N; Neuhaus A; Zurbruegg S; Volkmer P; Patino C; Joller S; Feuerbach D; Doelemeyer A; Schweizer T; Rudin S; Neumann U; Berth R; Frieauff W; Gasparini F; Shimshek DR
J Neuroinflammation; 2023 Feb; 20(1):29. PubMed ID: 36755323
[TBL] [Abstract][Full Text] [Related]
17. TREM2 activation alleviates neural damage via Akt/CREB/BDNF signalling after traumatic brain injury in mice.
Yan J; Zhang Y; Wang L; Li Z; Tang S; Wang Y; Gu N; Sun X; Li L
J Neuroinflammation; 2022 Dec; 19(1):289. PubMed ID: 36463233
[TBL] [Abstract][Full Text] [Related]
18. TREM2 promotes Aβ phagocytosis by upregulating C/EBPα-dependent CD36 expression in microglia.
Kim SM; Mun BR; Lee SJ; Joh Y; Lee HY; Ji KY; Choi HR; Lee EH; Kim EM; Jang JH; Song HW; Mook-Jung I; Choi WS; Kang HS
Sci Rep; 2017 Sep; 7(1):11118. PubMed ID: 28894284
[TBL] [Abstract][Full Text] [Related]
19. Trem2 deficiency impairs recovery and phagocytosis and dysregulates myeloid gene expression during virus-induced demyelination.
Hwang M; Savarin C; Kim J; Powers J; Towne N; Oh H; Bergmann CC
J Neuroinflammation; 2022 Nov; 19(1):267. PubMed ID: 36333761
[TBL] [Abstract][Full Text] [Related]
20. The Emerging Role of Triggering Receptor Expressed on Myeloid Cells 2 as a Target for Immunomodulation in Ischemic Stroke.
Gervois P; Lambrichts I
Front Immunol; 2019; 10():1668. PubMed ID: 31379859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
